Introduction and Exploration of Fulvestrant in Metastatic Breast Cancer

Moderator, Adam M. Brufsky, MD, PhD, introduces the panel for an in-depth discussion analyzing recent trials that explored the detection, management, and treatment of metastatic breast cancer. The expert panel includes: Sara Hurvitz, MD, Joyce O'Shaughnessy, MD, Edith A. Perez, MD, Hope S. Rugo, MD, and Andrew D. Seidman, MD. To begin this discussion, panelist analyze the phase III CONFIRM trial that examined a larger dose size of fulvestrant as a treatment for metastatic breast cancer.
For more from this discussion, visit www.onclive.com...